Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine

YOUNG KIM, PETRA ALPMANN, SABINE BLAUM-FEDER, SIMON KRÄMER, TOMOYUKI ENDO, DESHENG LU, DENNIS CARSON and INGO G.H. SCHMIDT-WOLF
In Vivo January 2011, 25 (1) 99-103;
YOUNG KIM
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETRA ALPMANN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SABINE BLAUM-FEDER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SIMON KRÄMER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOYUKI ENDO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DESHENG LU
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DENNIS CARSON
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
INGO G.H. SCHMIDT-WOLF
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ingo.schmidt-wolf@ukb.uni-bonn.de
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Flow cytometric analysis of PO in human OPM-2 myeloma cells. 1×105 cells were cultured with or without 0.1 μM PO for three days. Cell viability was measured by DIOC6 staining in flow cytometry. A representative experiment is shown.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Flow cytometric analysis of PO in murine MPC11 myeloma cells. 1×105 cells were cultured with various concentrations of PO for three days. Then cell viability was measured by DIOC6 staining in flow cytometry. Results represent data from two separate experiments. Data are shown as means.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    In vivo effect of PO in MPC11-bearing mice. PO was administered orally by gavage at a concentration of 450 μg/day/mouse. Tumor growth in mice is presented. Six animals were used in each group. The observation time was 60 days.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    In vivo effect of PO in MPC11-bearing mice. PO was administered orally by gavage at a concentration of 450 μg/day/mouse. Overall survival of mice is presented. Six animals were used in each group. The observation time was 60 days.

Tables

  • Figures
  • Table I.
PreviousNext
Back to top

In this issue

In Vivo: 25 (1)
In Vivo
Vol. 25, Issue 1
January-February 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 13 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine
YOUNG KIM, PETRA ALPMANN, SABINE BLAUM-FEDER, SIMON KRÄMER, TOMOYUKI ENDO, DESHENG LU, DENNIS CARSON, INGO G.H. SCHMIDT-WOLF
In Vivo Jan 2011, 25 (1) 99-103;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Increased In Vivo Efficacy of Lenalidomide by Addition of Piroctone Olamine
YOUNG KIM, PETRA ALPMANN, SABINE BLAUM-FEDER, SIMON KRÄMER, TOMOYUKI ENDO, DESHENG LU, DENNIS CARSON, INGO G.H. SCHMIDT-WOLF
In Vivo Jan 2011, 25 (1) 99-103;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • In Vitro Apoptosis Induction by Fenofibrate in Lymphoma and Multiple Myeloma
  • Griseofulvin Efficiently Induces Apoptosis in In Vitro Treatment of Lymphoma and Multiple Myeloma
  • Targeting Prostate Cancer with a Combination of WNT Inhibitors and a Bi-functional Peptide
  • Clofibrate Demonstrates Efficacy in In Vitro Treatment of Lymphoma and Multiple Myeloma
  • In Vitro Efficacy of Naftifine Against Lymphoma and Multiple Myeloma
  • Flunarizine Exhibits In Vitro Efficacy Against Lymphoma and Multiple Myeloma Cells
  • In Vitro Efficacy of Cinnarizine Against Lymphoma and Multiple Myeloma
  • Effect of Wnt Inhibitors in Pancreatic Cancer
  • Targeting the Wnt/Beta-Catenin Pathway in Renal Cell Carcinoma
  • Targeting Renal Cancer with a Combination of WNT Inhibitors and a Bi-Functional Peptide
  • Targeting the Wnt/Beta-catenin Pathway with the Antifungal Agent Ciclopirox Olamine in a Murine Myeloma Model
  • Increased In vivo Efficacy of Lenalidomide and Thalidomide by Addition of Ethacrynic Acid
  • Influencing the Wnt Signaling Pathway in Multiple Myeloma
  • Google Scholar

More in this TOC Section

  • Systemic Administration of Lipopolysaccharide from Porphyromonas gingivalis Decreases Neprilysin Expression in the Mouse Hippocampus
  • Monitoring T-Cell Kinetics in the Early Recovery Period of Lung Transplantation Cases by Copy Number Levels of T-Cell Receptor Excision Circle
  • Successful Surgical Outcome of Feline Inductive Odontogenic Tumor in Three Cats
Show more Experimental Studies

Similar Articles

In Vivo

© 2023 In Vivo

Powered by HighWire